Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Unlike arginine vasopressin, the selective V
1a
receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor
Sebastian Rehberg
,
Perenlei Enkhbaatar
, Janina Rehberg
, Erin La
, Nicky Ferdyan
, Steve Qi
, Kazimierz Wisniewski
, Lillian D. Traber
, Claudio D. Schteingart
, Pierre J.M. Rivière
, Régent Laporte
, Daniel L. Traber
Anesthesiology
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Unlike arginine vasopressin, the selective V
1a
receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Receptor Agonist
100%
Arginine Vasopressin
100%
Von Willebrand Factor
100%
Procoagulant Effect
100%
Vasopressin
87%
Vasopressin V2 Receptor
37%
Sheep
25%
Septic Shock
25%
Desmopressin (DDAVP)
25%
Receptor-mediated
12%
Sodium Chloride
12%
Sham
12%
Hemoglobin Concentration
12%
Inflammatory Pathways
12%
Potential Gains
12%
Prospective Randomized Trial
12%
Animal Research
12%
Controlled Experiment
12%
2 Receptor
12%
Continuous Intravenous Infusion
12%
Intravenous Bolus
12%
Antigen Activity
12%
Von Willebrand Factor Antigen
12%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor Agonist
100%
Procoagulant
100%
Argipressin
100%
Von Willebrand Factor
100%
Vasopressin
100%
Septic Shock
22%
Desmopressin
22%
Receptor
11%
Vasopressin V1a Receptor
11%